Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-08-12 Sale | 2022-08-16 5:36 pm | Xenon Pharmaceuticals Inc. | XENE | EMPFIELD JAMES R. EVP, Drug Discovery | 57,743 | $38.31 | $2,211,978 | 10,000 (Direct) | View |
| 2022-03-04 Sale | 2022-03-08 7:32 pm | Xenon Pharmaceuticals Inc. | XENE | EMPFIELD JAMES R. EVP, Drug Discovery | 51,168 | $30.63 | $1,567,394 | 10,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-03-11 Option Award | 2024-03-12 6:37 pm | N/A 2034-03-10 | Xenon Pharmaceuticals Inc. | XENE | EMPFIELD JAMES R. EVP, Drug Discovery | 65,000 | $0 | 65,000 (Direct) | View |
| 2023-03-10 Option Award | 2023-03-14 4:27 pm | N/A 2033-03-09 | Xenon Pharmaceuticals Inc. | XENE | EMPFIELD JAMES R. EVP, Drug Discovery | 75,000 | $0 | 75,000 (Direct) | View |
| 2022-08-12 Exercise | 2022-08-16 5:36 pm | N/A 2027-10-22 | Xenon Pharmaceuticals Inc. | XENE | EMPFIELD JAMES R. EVP, Drug Discovery | 65,000 | $0 | 10,000 (Direct) | View |
| 2022-08-12 Exercise | 2022-08-16 5:36 pm | N/A N/A | Xenon Pharmaceuticals Inc. | XENE | EMPFIELD JAMES R. EVP, Drug Discovery | 20,000 | $3.1 | 10,000 (Direct) | View |
| 2022-08-12 Tax Withholding | 2022-08-16 5:36 pm | N/A N/A | Xenon Pharmaceuticals Inc. | XENE | EMPFIELD JAMES R. EVP, Drug Discovery | 7,257 | $38.02 | 10,000 (Direct) | View |
| 2022-08-12 Exercise | 2022-08-16 5:36 pm | N/A N/A | Xenon Pharmaceuticals Inc. | XENE | EMPFIELD JAMES R. EVP, Drug Discovery | 45,000 | $4.75 | 10,000 (Direct) | View |
| 2022-03-10 Option Award | 2022-03-14 4:10 pm | N/A 2032-03-09 | Xenon Pharmaceuticals Inc. | XENE | EMPFIELD JAMES R. EVP, Drug Discovery | 65,000 | $0 | 65,000 (Direct) | View |
| 2022-03-04 Exercise | 2022-03-08 7:32 pm | N/A 2027-03-12 | Xenon Pharmaceuticals Inc. | XENE | EMPFIELD JAMES R. EVP, Drug Discovery | 67,500 | $0 | 10,000 (Direct) | View |
| 2022-03-04 Exercise | 2022-03-08 7:32 pm | N/A N/A | Xenon Pharmaceuticals Inc. | XENE | EMPFIELD JAMES R. EVP, Drug Discovery | 27,500 | $8.4 | 10,000 (Direct) | View |
| 2022-03-07 Tax Withholding | 2022-03-08 7:32 pm | N/A N/A | Xenon Pharmaceuticals Inc. | XENE | EMPFIELD JAMES R. EVP, Drug Discovery | 9,647 | $30.23 | 10,000 (Direct) | View |
| 2022-03-07 Exercise | 2022-03-08 7:32 pm | N/A N/A | Xenon Pharmaceuticals Inc. | XENE | EMPFIELD JAMES R. EVP, Drug Discovery | 40,000 | $6.76 | 10,000 (Direct) | View |
| 2022-03-04 Tax Withholding | 2022-03-08 7:32 pm | N/A N/A | Xenon Pharmaceuticals Inc. | XENE | EMPFIELD JAMES R. EVP, Drug Discovery | 6,685 | $31.42 | 10,000 (Direct) | View |
| 2021-03-12 Option Award | 2021-03-15 4:35 pm | N/A 2031-03-11 | Xenon Pharmaceuticals Inc. | XENE | EMPFIELD JAMES R. EVP, Drug Discovery | 65,000 | $0 | 65,000 (Direct) | View |
| 2020-03-12 Option Award | 2020-03-13 5:12 pm | N/A 2030-03-11 | Xenon Pharmaceuticals Inc. | XENE | EMPFIELD JAMES R. SVP, Drug Discovery | 65,000 | $0 | 65,000 (Direct) | View |